ADMA Biologics is followed by the analysts listed here. Please note that any opinions, estimates, or forecasts regarding ADMA Biologics' performance made by these analysts are theirs alone and do not represent opinions, forecasts, or predictions of ADMA Biologics or its management. ADMA Biologics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions, or recommendations.

Firm Analyst
Cantor Fitzgerald Kristen Kluska
H. C. Wainwright & Co. Raghuram Selvaraju, Ph.D.
Laidlaw & Company (UK) Ltd. Yale Jen, Ph.D.
Raymond James & Associates, Inc. Elliot Wilbur, CFA